Klinika Oczna

Abstract

2/2024 vol. 126
Review paper

Macular abnormalities in retinitis pigmentosa. Management and treatment

  1. 2nd Department of Ophthalmology, Pomeranian Medical University in Szczecin, Poland
KLINIKA OCZNA 2024, 126, 2: 59-64
Online publish date: 2024/05/22
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Aim

To review the current state of knowledge on macular in retinitis pigmentosa, current treatment methods and management.

Material and methods

Analysis of literature available on PubMed. Presentation of own treatment results.

Results

Macular lesions occur in 11.5% to 59.7% of patients with pigmentary degeneration. The most commonly observed macular abnormalities include cystoid macular edema, epiretinal membranes, vitreomacular traction syndrome, and full-thickness macular holes. In conservative treatment, topical carbonic anhydrase inhibitors and steroids are the most effective. The best surgical treatment outcomes have been obtained for macular holes. Conservative and surgical treatment outcomes vary and depend on the stage of retinitis pigmentosa.

Conclusions

Macular abnormalities are often observed in patients with retinitis pigmentosa. arbonic anhydrase blockers and steroids can be effective in treating cystoid macular edema. Surgical treatment can improve macular morphology but improvement in visual function is limited due to long-term retinal dysfunction and progression of the underlying disease.

Share
without publication fees
without publication fees